The EU Unitary Patent – Overview and Practical Considerations

Nov 4, 2014

The preparations have spanned almost 40 years, and there have been many significant obstacles to overcome. However, the “Unitary Patent” and the dedicated “Unitary Patent Court (UPC)”are now an inevitability. Jon Gowshall and Charlotte Fox of Forresters give an overview of the new system and look at some of the practical implications of the Unitary Patent and UPC for patent owners. The UPC agreement was signed on 19 February 2013, and will come into force as soon as it has been ratified by enough countries (thirteen including the UK, Germany, and France), probably in 2015. ...

Read More

Influence of Primary Components on Parenteral Delivery Systems, Biologic Therapies and Patient Outcome

Jul 1, 2014

The administration of parenteral biologics relies on interconnected attributes associated with compatibility of delivery components to the safety and efficacy of the final product. Diane Paskiet and Simon Côté of WestPharma address the importance of characterising individual components in contact with a biologic, to understand the risks to the delivery system as a whole and the effect on patient outcome. And selecting an appropriate delivery system for these therapies is critically important. ...

Read More

New Technologies in the Fight Against a Global Pandemic

Jul 1, 2014

The global market for insulin therapies is growing at a much higher rate than total sales of prescription drugs. For people with diabetes who are dependent on insulin, pen systems that can be equipped with insulin cartridges and injection needles have long since surpassed all other injection systems. Dr Johannes Rauschnabel of Bosch Packaging Technology provides an analysis of the new technologies used by manufacturers for the safe filling of insulin cartridges, which ensure high output, low product loss, and optimal patient protection. ...

Read More

Parenteral Packaging: Raw Material Substitution and Procurement Impact

Jul 1, 2014

The industry of glass primary packaging is seeing a rapid shift towards the usage of plastic substitutes for specific end uses (biotech drug packaging, prefilled syringes etc). M. Abhiraj of Beroe Inc. deals with the underlying facts related to the issue of glass substitution, taking into consideration the cost of recalls and total cost of ownership, but also the impact substitution has over procurement factors such as raw material sourcing, industry integration, and manufacturing of packaging. ...

Read More

The Hidden Challenges of Pharmaceutical Serialisation

Jul 1, 2014

In the almost 40 years since counterfeiting of pharmaceutical products was recognised as a problem by the World Health Organization (WHO), the industry has waged a constant battle against increasingly sophisticated and organised counterfeiters, with drug packaging serving as one of its foremost defences. Craig Stobie of Domino looks into the technical challenges and commercial benefits of implementing item-level serialisation. ...

Read More